EUVIMEDEUVIMED entdecken
Open Access

Spotted fever rickettsia-induced microvascular endothelial barrier dysfunction is delayed by the calcium channel blocker benidipine

Yuri Kim, Emily G Clemens, Jennifer M Farner, Andres Londono-Barbaran, Dennis J Grab, J Stephen Dumler

Biochemical and Biophysical Research Communications · 2023-06 · 663 · 96-103

DOI: 10.1016/j.bbrc.2023.04.045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2023-06. Verfasst von Yuri Kim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Henry M. Jackson Foundation for the Advancement of Military Medicine, 4301 Jones Bridge Road, Bethesda, MD, 20814, USA; Uniformed Services of the Hea…. Hauptthemen laut MEDLINE: Dihydropyridines, Rickettsia, Spotted Fever Group Rickettsiosis, Vascular Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The tick-borne bacterium Rickettsia parkeri is an obligate intracellular pathogen that belongs to spotted fever group rickettsia (SFGR). The SFG pathogens are characterized by their ability to infect and rapidly proliferate inside host vascular endothelial cells that eventually result in impairment of vascular endothelium barrier functions. Benidipine, a wide range dihydropyridine calcium channel blocker, is used to prevent and treat cardiovascular diseases. In this study, we tested whether benidipine has protective effects against rickettsia-induced microvascular endothelial cell barrier dysfunction in vitro. We utilized an in vitro vascular model consisting of transformed human brain microvascular endothelial cells (tHBMECs) and continuously monitored transendothelial electric resistance (TEER) across the cell monolayer. We found that during the late stages of infection when we observed TEER decrease and when there was a gradual increase of the cytoplasmic [Ca2+], benidipine prevented these rickettsia-induced effects. In contrast, nifedipine, another cardiovascular dihydropyridine channel blocker specific for L-type Ca2+ channels, did not prevent R. parkeri-induced drop of TEER. Additionally, neither drug was bactericidal. These data suggest that growth of R. parkeri inside endothelial cells is associated with impairment of endothelial cell monolayer integrity due to Ca2+ flooding through specific, benidipine-sensitive T- or N/Q-type Ca2+ channels but not through nifedipine-sensitive L-type Ca2+ channels. Further study will be required to discern the exact nature of the Ca2+ channels and Ca2+ transporting system(s) involved, any contributions of the pathogen toward this process, as well as the suitability of benidipine and new dihydropyridine derivatives as complimentary therapeutic drugs against Rickettsia-induced vascular failure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DihydropyridinesRickettsiaSpotted Fever Group RickettsiosisVascular DiseasesHumansCalcium Channel BlockersEndothelial CellsNifedipine

Stichwörter der Autor:innen

BenidipineBrain microvascular endothelial cellsCalcium channel blockersElectric cell impedance sensingNifedipineSpotted fever group RickettsiaVascular permeability

Substanzen

Calcium Channel BlockersbenidipineNifedipineDihydropyridines

Autor:innen und Institutionen

  • Henry M. Jackson Foundation for the Advancement of Military Medicine, 4301 Jones Bridge Road, Bethesda, MD, 20814, USA; Uniformed Services of the Health Sciences, Department of Pathology, 4301 Jones Bridge Road, Bethesd…
  • Uniformed Services of the Health Sciences, Department of Pathology, 4301 Jones Bridge Road, Bethesda, MD, 20814, USA. Electronic address: emily.clemens@usuhs.edu.
  • Uniformed Services of the Health Sciences, Department of Pathology, 4301 Jones Bridge Road, Bethesda, MD, 20814, USA. Electronic address: dennis.grab@usuhs.edu.
  • Uniformed Services of the Health Sciences, Department of Pathology, 4301 Jones Bridge Road, Bethesda, MD, 20814, USA. Electronic address: john.dumler@usuhs.edu.

Förderung

  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases
  • National Institute of Allergy and Infectious Diseases
  • US Office of Congressionally Directed Medical Research Programs

Zitieren

APA

Kim, Y., Clemens, E. G., Farner, J. M., Londono-Barbaran, A., Grab, D. J., & Dumler, J. S. (2023). Spotted fever rickettsia-induced microvascular endothelial barrier dysfunction is delayed by the calcium channel blocker benidipine. Biochemical and Biophysical Research Communications, 663, 96-103. https://doi.org/10.1016/j.bbrc.2023.04.045

Vancouver

Kim Y, Clemens EG, Farner JM, Londono-Barbaran A, Grab DJ, Dumler JS. Spotted fever rickettsia-induced microvascular endothelial barrier dysfunction is delayed by the calcium channel blocker benidipine. Biochemical and Biophysical Research Communications. 2023;663:96-103. doi:10.1016/j.bbrc.2023.04.045

BibTeX
@article{Kim2023,
  author = {Kim, Yuri and Clemens, Emily G and Farner, Jennifer M and Londono-Barbaran, Andres and Grab, Dennis J and Dumler, J Stephen},
  title = {Spotted fever rickettsia-induced microvascular endothelial barrier dysfunction is delayed by the calcium channel blocker benidipine},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2023},
  volume = {663},
  pages = {96--103},
  doi = {10.1016/j.bbrc.2023.04.045}
}
Kostenlos starten →